This announcement is a separate document:
双成药业：海南双成药业股份有限公司监事会关于2021年股票期权与限制性股票激励计划回购注销部分激励对象已获授但尚未解除限售的限制性股票事项的核查意见
Hainan Shuangcheng Pharmaceuticals: Inspection opinions of the board of supervisors of Hainan Shuangcheng Pharmaceutical Co., Ltd. on restricted stocks that have been granted to repurchase and cancel some incentive recipients of the 2021 Stock Options and Restricted Stock Incentive Plan but whose sales restrictions have not yet been lifted
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.